{"transactions":[{"id":710877,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2026-07-13T20:41:33.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":false,"shares":17167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":17167,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":17167},"source":{"system":"sec-edgar","filing":"0001470831-26-000709","document":"wk-form4_1783975290.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000147083126000709/wk-form4_1783975290.xml","form_type":"4"}},{"id":710876,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:41:33.000Z","date":"2026-07-09","kind":"sale","planned":true,"acquired":false,"shares":17167,"price":84,"value":1442028.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025."}],"balance_after":22579,"source":{"system":"sec-edgar","filing":"0001470831-26-000709","document":"wk-form4_1783975290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000147083126000709/wk-form4_1783975290.xml","form_type":"4"}},{"id":710875,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-13T20:41:33.000Z","date":"2026-07-09","kind":"exercise","planned":true,"acquired":true,"shares":17167,"price":16.75,"value":287547.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025."}],"balance_after":39746,"source":{"system":"sec-edgar","filing":"0001470831-26-000709","document":"wk-form4_1783975290.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000147083126000709/wk-form4_1783975290.xml","form_type":"4"}},{"id":728194,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T22:05:52.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":5277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."}],"balance_after":5277,"derivative":{"exercise_price":68.92,"expiration_date":"2036-06-21","underlying":"Common Stock","underlying_shares":5277},"source":{"system":"sec-edgar","filing":"0001470831-26-000630","document":"wk-form4_1782338749.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000147083126000630/wk-form4_1782338749.xml","form_type":"4"}},{"id":728193,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T22:05:52.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":3990,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":22579,"source":{"system":"sec-edgar","filing":"0001470831-26-000630","document":"wk-form4_1782338749.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000147083126000630/wk-form4_1782338749.xml","form_type":"4"}},{"id":857020,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2026-03-06T21:57:57.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":false,"shares":64921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":64921},"source":{"system":"sec-edgar","filing":"0001470831-26-000252","document":"wk-form4_1772834274.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000147083126000252/wk-form4_1772834274.xml","form_type":"4"}},{"id":857019,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-06T21:57:57.000Z","date":"2026-03-04","kind":"sale","planned":true,"acquired":false,"shares":64921,"price":64.8681,"value":4211301.9201,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 3, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $64.255 to $65.21 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote."}],"balance_after":18589,"source":{"system":"sec-edgar","filing":"0001470831-26-000252","document":"wk-form4_1772834274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000147083126000252/wk-form4_1772834274.xml","form_type":"4"}},{"id":857018,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-06T21:57:57.000Z","date":"2026-03-04","kind":"exercise","planned":true,"acquired":true,"shares":64921,"price":8.45,"value":548582.45,"ownership":{"direct":true},"balance_after":83510,"source":{"system":"sec-edgar","filing":"0001470831-26-000252","document":"wk-form4_1772834274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000147083126000252/wk-form4_1772834274.xml","form_type":"4"}},{"id":1072674,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-08-07T20:50:17.000Z","date":"2025-08-05","kind":"exercise","planned":true,"acquired":false,"shares":17167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in three annual installments from June 21, 2024 through June 21, 2026, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":34334,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":17167},"source":{"system":"sec-edgar","filing":"0000950170-25-105185","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025105185/ownership.xml","form_type":"4"}},{"id":1072673,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-07T20:50:17.000Z","date":"2025-08-05","kind":"sale","planned":true,"acquired":false,"shares":17167,"price":49,"value":841183.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":18589,"source":{"system":"sec-edgar","filing":"0000950170-25-105185","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025105185/ownership.xml","form_type":"4"}},{"id":1072672,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-07T20:50:17.000Z","date":"2025-08-05","kind":"exercise","planned":true,"acquired":true,"shares":17167,"price":16.75,"value":287547.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":35756,"source":{"system":"sec-edgar","filing":"0000950170-25-105185","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025105185/ownership.xml","form_type":"4"}},{"id":1103276,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-24T23:12:54.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":8425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares underlying the stock option will vest each year after June 20, 2025, such that all of the underlying shares will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."}],"balance_after":8425,"derivative":{"exercise_price":41.73,"expiration_date":"2035-06-19","underlying":"Common Stock","underlying_shares":8425},"source":{"system":"sec-edgar","filing":"0000950170-25-089673","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025089673/ownership.xml","form_type":"4"}},{"id":1103275,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T23:12:54.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":6589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Grant of restricted stock units (\"RSUs\") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan.  One-third of the RSUs will vest each year after June 20, 2025, such that all of the units will be vested on June 20, 2028, subject to the Reporting Person's continued service on the Issuer's board of directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's Common Stock."}],"balance_after":18589,"source":{"system":"sec-edgar","filing":"0000950170-25-089673","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025089673/ownership.xml","form_type":"4"}},{"id":1171339,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-04-16T21:39:06.000Z","date":"2025-04-14","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":64921,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000950170-25-054883","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025054883/ownership.xml","form_type":"4"}},{"id":1171338,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-16T21:39:06.000Z","date":"2025-04-14","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":35,"value":350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000950170-25-054883","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025054883/ownership.xml","form_type":"4"}},{"id":1171337,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-16T21:39:06.000Z","date":"2025-04-14","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":8.45,"value":84500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":22000,"source":{"system":"sec-edgar","filing":"0000950170-25-054883","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025054883/ownership.xml","form_type":"4"}},{"id":1181134,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-04-03T21:11:15.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in three annual installments starting on June 22, 2023 and ending on June 22, 2025, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":74921,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000950170-25-050584","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025050584/ownership.xml","form_type":"4"}},{"id":1181133,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T21:11:15.000Z","date":"2025-04-01","kind":"sale","planned":true,"acquired":false,"shares":30000,"price":34.05,"value":1021500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000950170-25-050584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025050584/ownership.xml","form_type":"4"}},{"id":1181132,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-03T21:11:15.000Z","date":"2025-04-01","kind":"exercise","planned":true,"acquired":true,"shares":30000,"price":8.45,"value":253500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on December 30, 2024."}],"balance_after":42000,"source":{"system":"sec-edgar","filing":"0000950170-25-050584","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017025050584/ownership.xml","form_type":"4"}},{"id":1469980,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-25T21:39:13.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":26014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying the stock option will vest each year after June 21, 2024, such that all of the underlying shares will be vested on June 21, 2027, subject to the Reporting Person's continued service on the board of directors of the Issuer."}],"balance_after":26014,"derivative":{"exercise_price":27.36,"expiration_date":"2034-06-20","underlying":"Common Stock","underlying_shares":26014},"source":{"system":"sec-edgar","filing":"0000950170-24-077443","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000095017024077443/ownership.xml","form_type":"4"}},{"id":1845756,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-23T20:18:35.000Z","date":"2023-06-21","kind":"grant","planned":false,"acquired":true,"shares":51501,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 21, 2024; thereafter, 1/3rd of the underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on June 21, 2026, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":51501,"derivative":{"exercise_price":16.75,"expiration_date":"2033-06-21","underlying":"Common Stock","underlying_shares":51501},"source":{"system":"sec-edgar","filing":"0001209191-23-039369","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000120919123039369/doc4.xml","form_type":"4"}},{"id":2222459,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-24T20:28:28.000Z","date":"2022-06-22","kind":"grant","acquired":true,"shares":104921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the shares underlying the option will vest on June 22, 2023; thereafter, 1/3rd of the remaining underlying shares will vest on an annual basis, so that all of the underlying shares will be vested on the June 22, 2025, subject to the optionee's continued service on the Board of Directors of the Company."}],"balance_after":104921,"derivative":{"exercise_price":8.45,"expiration_date":"2032-06-22","underlying":"Common Stock","underlying_shares":104921},"source":{"system":"sec-edgar","filing":"0001209191-22-039241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000120919122039241/doc4.xml","form_type":"4"}},{"id":2329131,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-17T20:05:56.000Z","date":"2022-03-15","kind":"purchase","acquired":true,"shares":12000,"price":8.39,"value":100680.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price of the shares purchased from $8.38 to $8.40 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price for all transactions as reported in this footnote."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0000899243-22-011386","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000089924322011386/doc4.xml","form_type":"4"}},{"id":2590091,"issuer":{"id":3360,"kind":"organization","name":"BridgeBio Pharma, Inc.","symbol":"BBIO"},"owners":[{"id":30882,"kind":"person","name":"Ellis Andrea","position":1,"cik":"0001877680","reported_name":"Ellis Andrea","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-08-26T21:14:43.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":49869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in three annual installments after August 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date."}],"balance_after":49869,"derivative":{"exercise_price":49.54,"expiration_date":"2031-08-16","underlying":"Common Stock","underlying_shares":49869},"source":{"system":"sec-edgar","filing":"0000899243-21-034290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877680/000089924321034290/doc4.xml","form_type":"4"}}]}